Esperion Therapeutics | Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -2.64B 2.46B 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
Alterity Therapeutics Limited AUD 22.81M 5.29M 2023-06
Amarin USD 458.89M 6.03M 2025-09
Amgen USD 9.62B 2.19B 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Cipla INR 329.19B 16.3B 2025-09
CSL USD 21.41B 861M 2025-06
Cytokinetics USD -521.12M 216.32M 2025-09
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Eli Lilly USD 23.79B 5.52B 2025-09
Esperion Therapeutics USD -451.36M 17.85M 2025-09
Geron USD 248.71M 10.82M 2025-09
Grifols EUR 6.08B 34.72M 2025-09
Halozyme Therapeutics USD 503.92M 171.17M 2025-09
Heron Therapeutics USD 14.88M 42.14M 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Merck USD 51.85B 2.79B 2025-09
Minerva Neurosciences USD -34.58M 2.47M 2025-09
Moderna USD 9.33B 69M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -155.76M 50.79M 2025-09
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
United Therapeutics USD 6.59B 583.4M 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09


Esperion Therapeutics Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.